Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19.
Identifieur interne : 000464 ( Main/Corpus ); précédent : 000463; suivant : 000465Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19.
Auteurs : Qiuyu Li ; Cheng Cui ; Fei Xu ; Jianping Zhao ; Nan Li ; Haichao Li ; Tianbing Wang ; Hua Zhang ; Na Liu ; Yudong Wei ; Xiaoye Niu ; Yan Xu ; Jianping Dong ; Xueting Yao ; Xiaohong Wang ; Yahong Chen ; Haiyan Li ; Chunli Song ; Jie Qiao ; Dongyang Liu ; Ning ShenSource :
- Science China. Life sciences [ 1869-1889 ] ; 2021.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Chloroquine, Hydroxychloroquine.
- chemical , therapeutic use : Antiviral Agents.
- drug therapy : COVID-19.
- Humans, Pneumonia, SARS-CoV-2.
DOI: 10.1007/s11427-020-1871-4
PubMed: 33471276
PubMed Central: PMC7816738
Links to Exploration step
pubmed:33471276Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19.</title>
<author><name sortKey="Li, Qiuyu" sort="Li, Qiuyu" uniqKey="Li Q" first="Qiuyu" last="Li">Qiuyu Li</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cui, Cheng" sort="Cui, Cheng" uniqKey="Cui C" first="Cheng" last="Cui">Cheng Cui</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Xu, Fei" sort="Xu, Fei" uniqKey="Xu F" first="Fei" last="Xu">Fei Xu</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhao, Jianping" sort="Zhao, Jianping" uniqKey="Zhao J" first="Jianping" last="Zhao">Jianping Zhao</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Nan" sort="Li, Nan" uniqKey="Li N" first="Nan" last="Li">Nan Li</name>
<affiliation><nlm:affiliation>Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Haichao" sort="Li, Haichao" uniqKey="Li H" first="Haichao" last="Li">Haichao Li</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, 100034, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Tianbing" sort="Wang, Tianbing" uniqKey="Wang T" first="Tianbing" last="Wang">Tianbing Wang</name>
<affiliation><nlm:affiliation>Trauma Center, Peking University People's Hospital, Beijing, 100044, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhang, Hua" sort="Zhang, Hua" uniqKey="Zhang H" first="Hua" last="Zhang">Hua Zhang</name>
<affiliation><nlm:affiliation>Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Liu, Na" sort="Liu, Na" uniqKey="Liu N" first="Na" last="Liu">Na Liu</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Beijing Haidian Hospital, Haidian Section of Peking University Third Hospital, Beijing, 100080, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wei, Yudong" sort="Wei, Yudong" uniqKey="Wei Y" first="Yudong" last="Wei">Yudong Wei</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Niu, Xiaoye" sort="Niu, Xiaoye" uniqKey="Niu X" first="Xiaoye" last="Niu">Xiaoye Niu</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Xu, Yan" sort="Xu, Yan" uniqKey="Xu Y" first="Yan" last="Xu">Yan Xu</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dong, Jianping" sort="Dong, Jianping" uniqKey="Dong J" first="Jianping" last="Dong">Jianping Dong</name>
<affiliation><nlm:affiliation>Beijing Haidian Hospital, Haidian Section of Peking University Third Hospital, Beijing, 100080, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yao, Xueting" sort="Yao, Xueting" uniqKey="Yao X" first="Xueting" last="Yao">Xueting Yao</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Xiaohong" sort="Wang, Xiaohong" uniqKey="Wang X" first="Xiaohong" last="Wang">Xiaohong Wang</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chen, Yahong" sort="Chen, Yahong" uniqKey="Chen Y" first="Yahong" last="Chen">Yahong Chen</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Haiyan" sort="Li, Haiyan" uniqKey="Li H" first="Haiyan" last="Li">Haiyan Li</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Cardiology, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Song, Chunli" sort="Song, Chunli" uniqKey="Song C" first="Chunli" last="Song">Chunli Song</name>
<affiliation><nlm:affiliation>Institute of Medical Innovation, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Qiao, Jie" sort="Qiao, Jie" uniqKey="Qiao J" first="Jie" last="Qiao">Jie Qiao</name>
<affiliation><nlm:affiliation>Institute of Medical Innovation, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Liu, Dongyang" sort="Liu, Dongyang" uniqKey="Liu D" first="Dongyang" last="Liu">Dongyang Liu</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China. liudongyang@vip.sina.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shen, Ning" sort="Shen, Ning" uniqKey="Shen N" first="Ning" last="Shen">Ning Shen</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China. shenning1972@126.com.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33471276</idno>
<idno type="pmid">33471276</idno>
<idno type="doi">10.1007/s11427-020-1871-4</idno>
<idno type="pmc">PMC7816738</idno>
<idno type="wicri:Area/Main/Corpus">000464</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000464</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19.</title>
<author><name sortKey="Li, Qiuyu" sort="Li, Qiuyu" uniqKey="Li Q" first="Qiuyu" last="Li">Qiuyu Li</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cui, Cheng" sort="Cui, Cheng" uniqKey="Cui C" first="Cheng" last="Cui">Cheng Cui</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Xu, Fei" sort="Xu, Fei" uniqKey="Xu F" first="Fei" last="Xu">Fei Xu</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhao, Jianping" sort="Zhao, Jianping" uniqKey="Zhao J" first="Jianping" last="Zhao">Jianping Zhao</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Nan" sort="Li, Nan" uniqKey="Li N" first="Nan" last="Li">Nan Li</name>
<affiliation><nlm:affiliation>Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Haichao" sort="Li, Haichao" uniqKey="Li H" first="Haichao" last="Li">Haichao Li</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, 100034, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Tianbing" sort="Wang, Tianbing" uniqKey="Wang T" first="Tianbing" last="Wang">Tianbing Wang</name>
<affiliation><nlm:affiliation>Trauma Center, Peking University People's Hospital, Beijing, 100044, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhang, Hua" sort="Zhang, Hua" uniqKey="Zhang H" first="Hua" last="Zhang">Hua Zhang</name>
<affiliation><nlm:affiliation>Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Liu, Na" sort="Liu, Na" uniqKey="Liu N" first="Na" last="Liu">Na Liu</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Beijing Haidian Hospital, Haidian Section of Peking University Third Hospital, Beijing, 100080, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wei, Yudong" sort="Wei, Yudong" uniqKey="Wei Y" first="Yudong" last="Wei">Yudong Wei</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Niu, Xiaoye" sort="Niu, Xiaoye" uniqKey="Niu X" first="Xiaoye" last="Niu">Xiaoye Niu</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Xu, Yan" sort="Xu, Yan" uniqKey="Xu Y" first="Yan" last="Xu">Yan Xu</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dong, Jianping" sort="Dong, Jianping" uniqKey="Dong J" first="Jianping" last="Dong">Jianping Dong</name>
<affiliation><nlm:affiliation>Beijing Haidian Hospital, Haidian Section of Peking University Third Hospital, Beijing, 100080, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yao, Xueting" sort="Yao, Xueting" uniqKey="Yao X" first="Xueting" last="Yao">Xueting Yao</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Xiaohong" sort="Wang, Xiaohong" uniqKey="Wang X" first="Xiaohong" last="Wang">Xiaohong Wang</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chen, Yahong" sort="Chen, Yahong" uniqKey="Chen Y" first="Yahong" last="Chen">Yahong Chen</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Haiyan" sort="Li, Haiyan" uniqKey="Li H" first="Haiyan" last="Li">Haiyan Li</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Cardiology, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Song, Chunli" sort="Song, Chunli" uniqKey="Song C" first="Chunli" last="Song">Chunli Song</name>
<affiliation><nlm:affiliation>Institute of Medical Innovation, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Qiao, Jie" sort="Qiao, Jie" uniqKey="Qiao J" first="Jie" last="Qiao">Jie Qiao</name>
<affiliation><nlm:affiliation>Institute of Medical Innovation, Peking University Third Hospital, Beijing, 100191, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Liu, Dongyang" sort="Liu, Dongyang" uniqKey="Liu D" first="Dongyang" last="Liu">Dongyang Liu</name>
<affiliation><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China. liudongyang@vip.sina.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shen, Ning" sort="Shen, Ning" uniqKey="Shen N" first="Ning" last="Shen">Ning Shen</name>
<affiliation><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China. shenning1972@126.com.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Science China. Life sciences</title>
<idno type="eISSN">1869-1889</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term>
<term>COVID-19 (drug therapy)</term>
<term>Chloroquine (adverse effects)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (adverse effects)</term>
<term>Pneumonia (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Pneumonia</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33471276</PMID>
<DateCompleted><Year>2021</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>04</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1869-1889</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>64</Volume>
<Issue>4</Issue>
<PubDate><Year>2021</Year>
<Month>04</Month>
</PubDate>
</JournalIssue>
<Title>Science China. Life sciences</Title>
<ISOAbbreviation>Sci China Life Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>660-663</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11427-020-1871-4</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName>
<ForeName>Qiuyu</ForeName>
<Initials>Q</Initials>
<AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Cui</LastName>
<ForeName>Cheng</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Xu</LastName>
<ForeName>Fei</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhao</LastName>
<ForeName>Jianping</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Nan</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Haichao</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, 100034, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Tianbing</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Trauma Center, Peking University People's Hospital, Beijing, 100044, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Hua</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Na</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Beijing Haidian Hospital, Haidian Section of Peking University Third Hospital, Beijing, 100080, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wei</LastName>
<ForeName>Yudong</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Niu</LastName>
<ForeName>Xiaoye</ForeName>
<Initials>X</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Xu</LastName>
<ForeName>Yan</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dong</LastName>
<ForeName>Jianping</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Beijing Haidian Hospital, Haidian Section of Peking University Third Hospital, Beijing, 100080, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yao</LastName>
<ForeName>Xueting</ForeName>
<Initials>X</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Xiaohong</ForeName>
<Initials>X</Initials>
<AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chen</LastName>
<ForeName>Yahong</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Haiyan</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Cardiology, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Song</LastName>
<ForeName>Chunli</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Innovation, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Qiao</LastName>
<ForeName>Jie</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Innovation, Peking University Third Hospital, Beijing, 100191, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Dongyang</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China. liudongyang@vip.sina.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shen</LastName>
<ForeName>Ning</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China. shenning1972@126.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2021</Year>
<Month>01</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>China</Country>
<MedlineTA>Sci China Life Sci</MedlineTA>
<NlmUniqueID>101529880</NlmUniqueID>
<ISSNLinking>1674-7305</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>J Thromb Haemost. 2020 May;18(5):1233-1234</RefSource>
<PMID Version="1">32291954</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>08</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>12</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2021</Year>
<Month>1</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>4</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2021</Year>
<Month>1</Month>
<Day>20</Day>
<Hour>12</Hour>
<Minute>24</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33471276</ArticleId>
<ArticleId IdType="doi">10.1007/s11427-020-1871-4</ArticleId>
<ArticleId IdType="pii">10.1007/s11427-020-1871-4</ArticleId>
<ArticleId IdType="pmc">PMC7816738</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Guan, W.J., Ni, Z.Y., Hu, Y., Liang, W.H., Ou, C.Q., He, J.X., Liu, L., Shan, H., Lei, C.L., Hui, D.S.C., et al. (2020). Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382, 1708–1720.</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506.</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S.M., Lau, E.H.Y., Wong, J.Y., et al. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382, 1199–1207.</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001316</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., Zhao, L., et al. (2020). Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 55, 102763.</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102763</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Moon, C. (2020). Fighting COVID-19 exhausts T cells. Nat Rev Immunol 20, 277.</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0304-7</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Piconi, S., Parisotto, S., Rizzardini, G., Passerini, S., Terzi, R., Argenteri, B., Meraviglia, P., Capetti, A., Biasin, M., Trabattoni, D., et al. (2011). Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders. Blood 118, 3263–3272.</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-01-329060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020). Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 71, 762–768.</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa248</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tang, N., Li, D., Wang, X., and Sun, Z. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18, 844–847.</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tang, W., Cao, Z., Han, M., Wang, Z., Chen, J., Sun, W., Wu, Y., Xiao, W., Liu, S., Chen, E., et al. (2020). Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ 369, m1849.</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1849</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Torigoe, M., Sakata, K., Ishii, A., Iwata, S., Nakayamada, S., and Tanaka, Y. (2018). Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition. Clin Immunol 195, 1–7.</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2018.07.003</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaninov, N. (2020). In the eye of the COVID-19 cytokine storm. Nat Rev Immunol 20, 277.</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0305-6</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054–1062.</Citation>
<ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000464 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000464 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:33471276 |texte= Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:33471276" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |